| Titre : | Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. (2002) |
| Auteurs : | Andrew-S ROWLAND ; Emichael BOHLIG ; Ajack NAFTEL ; Dale-P SANDLER ; L.I.L. STALLONE ; David-M UMBACH ; Coda. Westat Inc. Durham. NC. USA ; Epidemiology Branch. National Institute of Environmental Health Sciences. National Institutes of Health. Research Triangle Park. NC. USA |
| Type de document : | Article |
| Dans : | American journal of public health (vol. 92, n° 2, 2002) |
| Pagination : | 231-234 |
| Langues: | Anglais |
| Mots-clés : | Prévalence ; Thérapeutique ; Thérapeutique médicamenteuse ; Chimiothérapie ; Enfant ; Homme ; Enfant 6 9 ans ; Médicament psychotrope ; Epidémiologie ; Etats Unis ; Amérique ; Amérique du Nord |
| Résumé : | [BDSP. Notice produite par INIST-CNRS nz5m3R0x. Diffusion soumise à autorisation]. Objectives. This study estimated the prevalence of medication treatment for attention deficit-hyperactivity disorder (ADHD) among elementary school children in a North Carolina county. Methods. Parents of 7333 children in grades 1 through 5 in 17 public elementary schools were asked whether their child had ever been given a diagnosis of ADHD by a psychologist or physician and whether their child was currently taking medication to treat ADHD. Parents of 6099 children (83%) responded. Results. By parental report, 607 children (10%) had been given an ADHD diagnosis and 434 (7%) were receivingADHD medication treatment, Seventy-one% of the diagnosed children were receiving medication. Treatment rates varied by sex, race/ethnicity, and grade. Conclusions. If treatment patterns observed in this study are representative, the public health impact of ADHD may be underestimated. |

